-
Ambs S, Hussain S P, Harris C C. 1997. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J, 11: 443-448.
-
Ambs S, Merriam W G, Bennett W P, et al. 1998. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res, 58: 334-341.
-
Brennan P A, Controy B, Spedding A V, et al. 2000. Expression of inducible nitric oxide synthase and P53 in oral epithelial dyplasia. Oral Surg Oral Med Oral Radiol Endon, 90 (5): 624-629.
doi: 10.1067/moe.2000.108800
-
Ellie E, Loiseau H, Lafond F, et al. 1995. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport, 7: 294-296.
doi: 10.1097/00001756-199512000-00070
-
Erden E, Bulut A S, Sak S D, et al. 2005. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium:an immunohisto chemical study of 151 cases. Virchow Arch, 447 (1): 24-30.
doi: 10.1007/s00428-005-1250-2
-
Felley-Bosco E. 1998. Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev, 17: 25-37.
doi: 10.1023/A:1005948420548
-
Gallo O, Masini E, Morbidelli L, et al. 1998. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst, 90: 587-596.
doi: 10.1093/jnci/90.8.587
-
Geller D A, Billiar T R. 1998.Molecular biology of nitric oxide synthases. Cancer Metastasis Rev, 17: 7-23.
doi: 10.1023/A:1005940202801
-
James F, Crish, Frederic Bone, et al. 2000.Suprabasal expression of the human papillomavirus type 16 oncopro-teins in mouse epidermis alters expression of cell cycle regulatory proteins. Carcinogenesis, 21 (5): 1031-1037.
doi: 10.1093/carcin/21.5.1031
-
Lala P K, Orucevic A. 1998. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev, 17: 91-106
doi: 10.1023/A:1005960822365
-
Liu X, H Yuan, B Fu, et al. 2005. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem, 280: 10807-10816.
doi: 10.1074/jbc.M410343200
-
Liu L. 2006. Expression of P53 and iNOS in tumor of ovary and their dependability. J Medical Res, 35 (7): 71-73.(in Chinese)
-
Meng W, Hou G, JIA Y S, et al. 2004.Ralationship between iducible nitric oxide synthase and clinicopatho-logical parameters in breast cancer and its siginificance. J Treat Prev, 11 (8): 808-810.(in Chinese)
-
Nathan C, Xie Q. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem, 269: 13725-13728.
-
Reveneau S, Amouldb L, Jolimoy G, et al. 1999. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of proges-terone receptors. Lab Invest, 79 (10): 1215-1225.
-
Thomsen L L, Miles D W, Happerfield L, et al. 1995. Nitric oxide synthase activity in human breast cancer. Br J Cancer, 72:41-44.
doi: 10.1038/bjc.1995.274